Global Retirement Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Global Retirement Partners's CSTL Position: Q3 2026 in Review
Global Retirement Partners sold out of Castle Biosciences (CSTL) in Q3 2026, closing a stake of 1,100 shares — an estimated $26.2K sold.
Global Retirement Partners first reported a position in CSTL in Q4 2019 and held it in 25 quarters. The position peaked at $42.8K in Q4 2025. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Global Retirement Partners reported no remaining Castle Biosciences position as of Q3 2026 after selling out during the quarter.
- Global Retirement Partners sold 1,100 Castle Biosciences shares in Q3 2026, an estimated $26.2K.
- Global Retirement Partners first reported a position in Castle Biosciences in Q4 2019 and held it in 25 quarters.
- Global Retirement Partners's Castle Biosciences position peaked at $42.8K in Q4 2025.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.